Page last updated: 2024-11-04

sulfadiazine and Hydronephrosis

sulfadiazine has been researched along with Hydronephrosis in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Hydronephrosis: Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.

Research Excerpts

ExcerptRelevanceReference
"Sulfadiazine-nephropathy and -nephrolithiasis were well known complications of high dose sulfadiazine therapy 50 years ago."1.29[Sulfadiazine nephrolithiasis and nephropathy]. ( Furrer, H; Hess, B; Jaeger, P; von Overbeck, J, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furrer, H1
von Overbeck, J1
Jaeger, P1
Hess, B1
Colebunders, R1
Depraetere, K1
De Droogh, E1
Kamper, A1
Corthout, B1
Bottiau, E1

Other Studies

2 other studies available for sulfadiazine and Hydronephrosis

ArticleYear
[Sulfadiazine nephrolithiasis and nephropathy].
    Schweizerische medizinische Wochenschrift, 1994, Nov-19, Volume: 124, Issue:46

    Topics: Adult; AIDS-Related Opportunistic Infections; Bicarbonates; Fluid Therapy; HIV Infections; Humans; H

1994
Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine.
    JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR), 1999, Volume: 82, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkalies; Antiprotozoal Agents; Crystallization; Female; Flui

1999